From The Source
- Clarity Pharmaceuticals: QUARTERLY ACTIVITY REPORT
- Avecho Quarterly Activities Report and Appendix 4C
- AAMRI proudly carries on Franklin Women legacy through equity-focused programs
- AMA: Blame games distract from what’s really impacting costs for patients
- Be Wise, Immunise and help WA beat the flu this winter
- PBS: Cost Recovery Fees and Charges
- Alterity Therapeutics: Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update
- Artrya: QUARTERLY ACTIVITIES & CASHFLOW REPORT QUARTER ENDED 31 MARCH 2026
- CIS: A Better Track for NDIS Reform. Fix the flaws that caused blowout
- Tracking the behavioural and social drivers of adult influenza vaccination: Insights from Australia’s first serial survey
- AMA: Sugar tax needed to tackle Australia’s worsening obesity crisis
- AIHW: Medicare Benefits Scheme funded services: monthly data
